Diagnoplex closes Series A financing with Debiopharm - MarketLine Financial Deals

Diagnoplex closes Series A financing with Debiopharm

Diagnoplex closes Series A financing with Debiopharm - MarketLine Financial Deals
Diagnoplex closes Series A financing with Debiopharm
Published Jan 18, 2011
2 pages — Published Jan 18, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Diagnoplex, a developer of molecular cancer diagnostics, has received an investment in Series A financing from Debiopharm Group.

  
Source:
Document ID
MA47542_110124
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Diagnoplex closes Series A financing with Debiopharm" Jan 18, 2011. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Diagnoplex-closes-Series-A-financing-with-Debiopharm-2052-51698>
  
APA:
MarketLine Financial Deals. (2011). Diagnoplex closes Series A financing with Debiopharm Jan 18, 2011. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Diagnoplex-closes-Series-A-financing-with-Debiopharm-2052-51698>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.